Previous 10 | Next 10 |
Thinly traded micro cap Taiwan Liposome (NASDAQ: TLC ) surges 100% premarket on increased volume in reaction to its submission of an Investigational New Drug (IND) Application to the Taiwan Food and Drug Administration seeking sign off on a clinical trial of...
1% of oral dose for 30-fold lung exposure and reduced cardiotoxicity A cost-effective, easily accessible, user-friendly potential treatment/prevention option SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Aug. 14, 2020 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinica...
Quick Take PainReform ( PRFX ) intends to raise $23 million from the sale of its common stock in an IPO, according to an amended registration statement . The company is developing a reformulated pain relief medication for post-operative pain reduction. PRFX management has performed well...
Taiwan Liposome (NASDAQ: TLC ) : Q2 GAAP EPS of -$0.11 misses by $0.02 . More news on: Taiwan Liposome Company, Ltd., Earnings news and commentary, Healthcare stocks news, , Read more ...
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Aug. 05, 2020 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced financial results for the second quarter ...
Background: I am an orthopedic surgeon in a busy practice. I have used Flexion's (FLXN) knee arthritis product Zilretta clinically, and I have met with the sales representative from Flexion on three occasions. I have performed approximately 20 Zilretta injections. I do not think the proponents...
Gainers: InnerWorkings (NASDAQ: INWK ) +117% . More news on: InnerWorkings, Inc., Heat Biologics, Inc., Boxlight Corporation, Stocks on the move, , Read more ...
Gainers: China Finance Online (NASDAQ: JRJC ) +176% . More news on: China Finance Online Co. Limited, Genetic Technologies Limited, WISeKey International Holding AG, Stocks on the move, , Read more ...
Ultra-thinly traded micro cap Taiwan Liposome Company (NASDAQ: TLC ) jumps 36% premarket, albeit on less than 3K shares, in reaction to its announcement of a preprint manuscript detailing its strategy to treat COVID-19 with an inhalable version of malaria drug hydroxychloro...
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan , July 15, 2020 (GLOBE NEWSWIRE) -- TLC (Nasdaq: TLC, TWO: 4152), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced that a pre-print version of a manuscri...
News, Short Squeeze, Breakout and More Instantly...
Taiwan Liposome Company Ltd. Company Name:
TLC Stock Symbol:
NASDAQ Market:
Taiwan Liposome Company Ltd. Website:
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Professor David Hunter, Florance and Cope Chair of Rheumatology at the University of Sydney, presented detailed findings from the Phase 3 clinical trial of TLC599 at the American College of Rheumatology (ACR) Annual...
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, Nov. 08, 2023 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a late clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical needs in orthopedic disorders, today announced that the Abstract Sele...
SOUTH SAN FRANCISCO, Calif. and TAIPEI, Taiwan, June 13, 2022 (GLOBE NEWSWIRE) -- TLC BioSciences (TLC), a clinical-stage specialty pharmaceutical company developing novel nanomedicines to target areas of unmet medical need, today announced that it has entered a commercialization agreem...